The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).…
BIO5 Oro Valley today announced a collaboration with the Translational Genomics Research Institute (TGen) to develop new therapies for the treatment of Alzheimer’s and other neurodegenerative diseases. BIO5 Oro Valley…
A top official of the New York Yankees whose father passed from pancreatic cancer has joined a prestigious national panel organized by the Translational Genomics Research Institute (TGen) to fight…
Stealth Software CEO Gerard Warrens announced Tuesday that the Netherlands-based company will locate its United States headquarters in Arizona, which the company selected over Austin, New York and Silicon Valley.…
Arizona’s bioscience sector added jobs at nearly four times the national rate over the past decade and experienced double-digit job growth during the economic recovery, a new report shows. Since Arizona’s…
The sale of a 2008 Shelby GT Barrett-Jackson Edition (Lot #3009) and the raffle of a 40th Anniversary Corvette generated $129,000 for cancer research at the Translational Genomics Research Institute…
Described as a “big step forward” for research and treatment of Parkinson’s disease, new research from Mayo Clinic in Arizona and Banner Sun Health Research Institute suggests that testing a…
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and…
BioAccel and the City of Peoria announced that BioInspire has accepted a sixth company, Arizona based medical device startup Stimwave Technologies, Inc., into the medical device incubator facility in Peoria,.…
Clinical Research Advantage’s Finance Department received two national honors in this year’s Best in Biz Awards, the only independent business awards program judged by members of the press and industry…
Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research.…
Clinical Research Advantage (CRA) received top honors in this year’s Best in Biz Awards, the only independent business awards program judged by members of the press and industry analysts. CRA…
